From Startup Xynomic Pharma
Link to Full Article: http://xynomicpharma.com/en/234-2/
Xynomic Pharmaceuticals, Inc. (“Xynomic”) participates in the Privacy Shield, detailed information of which can be found at https://www.privacyshield.gov/welcome. Xynomic adheres to each of the Privacy Shield Principles and is committed to subjecting to the Principles all personal information received from the EU in reliance on the EU-U.S. Privacy Shield Framework.
The Federal Trade Commission has jurisdiction over Xynomic’s compliance with the Privacy Shield.
Under Privacy Shield Xynomic collects personal information including name, mailing or email address, and/or biometric data for research and development purpose.
Xynomic acknowledges that EU individuals have the right to access the personal information that we maintain about them. An EU individual who seeks access, or who seeks to correct, amend, or delete inaccurate data, should direct their query to email@example.com. If requested to remove data, we will respond within a reasonable timeframe.
Xynomic discloses personal information to business partners and vendors for research and development purpose.
We will also provide EU individuals with opt-out or opt-in choice before we share their data with third parties other than our agents, or before we use it for a purpose other than which it was originally collected or subsequently authorized.
To limit the use and disclosure of your personal information, please submit a written request to firstname.lastname@example.org.
Xynomic may be required to disclose personal information in response to a lawful request by public authorities, including to meet national security or law enforcement requirements. Xynomic is aware of potential liability in cases of onward transfer to third parties.
Xynomic is aware of the possibility, under certain limited conditions, for individuals to invoke binding arbitration before the Privacy Shield Panel to be created by the U.S. Department of Commerce and the European Commission.
This policy may be amended from time to time, consistent with the Privacy Shield Principles and applicable data protection and privacy laws and principles. We will make users of our application aware of changes to this policy either by posting to our website, through email, or other means. We will notify those who share Personal Data with us if we make changes that materially affect the way we handle Personal Data previously collected, and we will allow them to choose whether their Personal Data may be used in any materially different manner.
Please visit their site for more information: Xynomic Pharma.com
All,Biotechnology,Healthcare News,Startup News